The briefing
Emory University researchers provided proof-of-concept that venetoclax, an approved cancer therapy, eliminated HIV-infected cells in a nonhuman primate model. While preliminary, the findings point to a potential new avenue for HIV cure research pending human trials.
Original headline
Cancer drug eliminates HIV-infected cells in animal model study